Fundz
Back to SEC Filings
10-KMEDIUM RiskDETERIORATING

Stereotaxis, Inc.

Filed: Mar 12, 2026 CIK: 0001289340
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-K filing content

Stereotaxis shows significant operational distress with major liquidity concerns and ability to fund operations explicitly highlighted as a key risk. The company's forward-looking statements emphasize uncertainty around converting backlog to revenue and capital requirements, indicating cash flow challenges. Multiple critical business dependencies including regulatory approvals for new devices and partnership success suggest high execution risk.

Red Flags Detected (6)

Explicit mention of liquidity concerns and ability to fund operations as a key risk

Uncertainty around ability to convert backlog to revenue indicates cash flow issues

Heavy dependence on regulatory approvals for additional disposable interventional devices

3 more red flags detected

Key Takeaways

Company operates in specialized robotic surgical systems market with significant regulatory hurdles

Multiple product lines including Genesis RMN, Niobe, and various catheter systems suggest diversified portfolio

2 more takeaways

Filing Overview

Form TypeAnnual Report (10-K)
Filing DateMar 12, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence75%
Red Flags6

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.

View Full Filing on SEC.govBrowse More Filings